Work

Anti-angiogenic therapy for lung cancer

Year: 2009

Type: article

Abstract: This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the benefits and harms of angiogenesis inhibitors in the treatment of lung cancer when given alone, following or in combination with chemotherapy or chemo‐radiotherapy (in the case of locally advanced non‐metastatic NSCLC or limited stage SCLC).

Source: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858.cd008047

Authors: Nick Pavlakis, Gavin Marx, Shane White, Christopher W Lee, Mustafa Khasraw

Institutions: Royal North Shore Hospital, Austin Hospital, BC Cancer Agency, The University of Sydney, Memorial Sloan Kettering Cancer Center, National Health and Medical Research Council

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2109557190

FWCI:

Cites: 24

Cited by:

Related to: 10